IVD Medical pursues Nasdaq listing amid profit decline

IVD Medical Holding Limited intends to proceed with a proposed dual primary listing of its American depositary shares on the Nasdaq Stock Market.

The company anticipates a profit of not less than RMB33 million for the six months ended June 30, 2025, down from approximately RMB125 million in the same period last year due to higher administrative and selling expenses.